Prenatal counseling: Guidelines for the care of people with spina bifida

The guidelines are presented in Table 1. The first column is the recommendation, and the second column is the evidence supporting that recommendation.

These guidelines were drawn from evidence around SB and its impact on lifelong functional outcomes as well as antenatal counselling for disabling conditions. We recommend that all evidence-based treatment options be offered, including antenatal or fetal closure, closure after birth, termination of the pregnancy, and adoption [2, 4, 10, 11, 12, 13, 14]. In order for all of these options to be available, timely consultation should occur as soon as possible following the antenatal identification, between 18 and 20 weeks gestation [12, 13]. The fetal closure is an option until the end of the 25 th week gestation and should be offered at treatment centers with expertise in the surgical and obstetrical management of NTDs [11, 12, 14]. The surgery itself and the obstetrical implications should be reviewed by those surgeons and obstetricians with experience managing high risk pregnancies and/or providing care to infants with NTDs [12]. In addition, the option of delivery at term and closure following birth should be offered for those with open NTDs, explaining that cesarean delivery at 37 weeks gestation and closure within 24 hours of delivery is to be expected [15]. Parents or caregivers should be informed of the details of the surgery and the postoperative course, as well as the different likelihoods for specific maternal and fetal outcomes, particularly related to hydrocephalus in the infant, between the fetal and postnatal closures [13, 15]. For those parents not able to raise a child with medical complexity but not comfortable with termination, the option of adoption should be available. Lastly, termination of the pregnancy should be offered to the family [11].

Upon identification of an open NTD, the first step is to review the prenatal testing available to date and clarify any misunderstanding or confusion that exists [3]. The ultrasound, if at all unclear, should be repeated with a high resolution exam in a maternal fetal unit to clearly define the location and size of the NTD and confirm if it is open or closed [16]. In addition, the examination for secondary findings such as hydrocephalus should be done [16]. Given the association with other abnormalities, fetal echocardiography should be considered [13]. Genetic evaluation with amniocentesis should also be recommended, particularly for those considering fetal closure. The identification of genetic abnormality in the fetus has important implications for counseling regarding prognosis, pregnancy management, and whether in utero NTD closure is an option [17, 18]. Measurement of amniotic fluid acetylcholinesterase helps to differentiate between open and closed NTDs and is a component of many perioperative evaluations for fetal closure [17, 18]. Fetal MRI also may be considered, particularly if unclear findings on ultrasonography exist [19].

In order to make decisions, counseling should provide information that describes the likelihood of survival and the spectrum of medical conditions associated with NTDs [4, 12]. These include neurosurgical (hydrocephalus, Chiari II malformation, tethered cord syndrome), urological (neurogenic bladder, incontinence, social continence), gastrointestinal (constipation, neurogenic bowel, incontinence, social continence), orthopedic (ambulation probability, assistive devices, musculoskeletal complications), and dermatological (decubitus ulcers, sensory loss) conditions [1, 2]. Treatment options for these conditions should be reviewed with an emphasis on optimizing function, rather than ‘fixing’ [20].

The ideal team to provide this information includes specialists in fetal medicine/obstetrics familiar with the management of a pregnancy complicated by a prenatal diagnosis of an NTD [10, 11, 12]. These providers are often the first to encounter the family and introduce this life changing information (see below). In addition, key members of the team include neurosurgeons familiar with NTDs as they can provide detailed information about surgical approaches (both antenatal and postnatal) and provide both short-term and realistic long-term expectations for the child and family [11, 12]. Experts in clinical genetics clarify testing results, provide information about folic acid, and discuss recurrence risk as well as potential implications for future pregnancies [3, 7, 17, 18]. Developmental pediatricians, physiatrists, and advanced practice nurses provide a focus on developmental disabilities and focus on the optimization of function. These specialists can provide insight into potential medical needs as well as functional goals across a lifespan using evidence-based information [3, 20]. They also assist with resource identification, access to care, and utilization as well as caregiver support and mental health support. Social workers are another key member of the team as they provide emotional support and mental health screening. They can also facilitate links to local, national, and international financial resources and sources of emotional support [12, 14]. Urologists provide a key aspect of the care team as they can discuss options to optimize function, particularly as it relates to various degrees of urinary continence and social continence [12]. Orthopedic surgeons provide the management of skeletal growth, mobility, and function with participation and inclusion [12]. Lastly, it is beneficial for families to meet with the neonatal team, to understand what to expect at delivery, the likelihood of admission to the neonatal intensive care unit, as well as normal newborn care such as breastfeeding, support for breastfeeding and skin-to-skin care [11, 12, 14, 21, 22]. They can review what potential outcomes to expect should the child have additional support needs as a result of premature gestational age.

It is important that families understand that the etiology of NTDs is not completely understood and that the NTD was not caused by their actions. Counseling should include the importance of folic acid in diminishing the chance of a pregnancy being affected by an NTD, although it is not entirely preventative [23, 24]. The recurrence risk should be reviewed along with the 1991 US Public Health Service guideline for daily consumption of 4 milligrams (4000 micrograms) of folic acid beginning prior to conception (one month) and continuing through the first three months of the pregnancy (see Women’s Health Guidelines).

General principles around lesion level and outcomes should be reviewed, with an emphasis that specific predictions of function are challenging based on lesion level [15]. In addition, the consultation should include a discussion of what to expect cognitively, with acknowledgement that exact predictions of cognitive function are challenging. Rather, a description of the variety of challenges, such as specific aspects of learning, need for special education support, and learning skills being impacted should be reviewed [4, 12].

In addition to the discussion of medical care and outcomes, much of the counseling should focus on functioning and independence, including a discussion of disability [7]. These recommendations recognize that perceptions around disability are highly variable. It is essential, therefore, that the consultation be done in a value-neutral manner, avoiding words such as ‘risk’ or ‘bad news’, and instead using words that impart the importance of the decision, such as ‘significant outcome’ and ‘potential challenges’ [7]. We recommend using these value-neutral words as the condition is described in both medical and functional terms. This approach allows the family to assign their own values to the important news provided, rather than adopt the medical provider’s values or biases. It is recommended that the approach be collaborative, seeking to understand from the family their values and cultural beliefs with the goal of a shared decision making process [5, 7].

5. Discussion

This guideline was developed to help providers who care for pregnancies affected by SB, as well as those who care for SB postnatally, to conceptualize key components involved in prenatal counseling. Limited studies exist describing parental experiences and the variables that influence decision making. While short-term outcome data for prenatal surgery is promising, long-term outcome data are not yet available. In addition, there is limited data on trauma-informed care and this approach to prenatal counseling.

There is also limited data on intervention strategies to facilitate coping for parents and families as they navigate the health care system.

While there is some guidance to best practice approaches regarding counseling of families affected by SB prenatally, this is a rapidly changing field due to the intense interest and advances being made in the field of prenatal repair for this diagnosis. Further research is needed to understand what variables and data are helpful for decision making and research delineating parent experience with this process will assist in improving the counseling and support provided. Key components, however, will remain as outlined in this guideline: parental choice, collaborative shared decision making, and data provided in a value-neutral manner.